Clinical Trials Update: Nov. 24, 2008 U.S. News & World Report, DC - Nov 24, 2008 If you have moderate-to-severe active ulcerative colitis, and are being treated with or have failed treatment with: oral 5-aminosalicylates, ...
Source: Google News
Recent News and Articles on the Keywords: trials + update + 2005 Related to the article below (Last Update: 8/5/2008)
Tyson Gay update Los Angeles Times, CA - Aug 3, 2008 Gay said then that the injury would not stop him from competing at the Olympics in the 100, which he had won a week earlier at the trials. ... AssociatedPressall 690 news articles »
UPDATE 1-Russian court sets Khodorkovsky release hearing Reuters - Aug 4, 2008 Khodorkovsky, once Russia's richest man, was sentenced in 2005 to eight years in prison for tax evasion and fraud. His trial was viewed by many as a climax ...
Intensive Lipid Intervention in the Post-ENHANCE Era RedOrbit, TX - High- dose atorvastatin therapy has produced similar marked benefits in 2 acute coronary syndrome trials,3,4 in a recent stroke trial,5 and in other ...
Urologists Should Recognize the Cardiac Safety of Prescribed ... CNNMoney.com (press release) - In October 2005, the US Food and Drug Administration (FDA) suggested that new drugs under development, particularly agents with systemic bioavailability (ie ...
Peripheral Arterial Disease: Diagnosis and Management RedOrbit, TX - In patients with DM, a hemoglobin A]c level of less than 7.0% and as close to 6.0% as possible should be targeted.12 No controlled trials have directly ...
Here are the latest clinical trials, courtesy of CenterWatch:
Parkinson's Disease
People who are taking stable doses of carbidopa/levodopa and who experience loss of benefit between doses may qualify to participate in this clinical trial of an investigational drug. Participation is free. Research site located in Fresno, Calif.
Premenstrual dysphoric disorder (PMDD) is a severe form of PMS (premenstrual syndrome), which affects about 5 percent of menstruating women. Like PMS, PMDD occurs the week before the onset of menstruation and disappears a few days thereafter. Females between 18 and 49 who are in good health and have symptoms consistent with a diagnosis of PMDD for at least one year may be eligible. Research site located in Washington, DC.
This study will determine whether two medicines, bicalutamide (anti-androgen) and anastrozole (aromatase inhibitor), will help boys who have started puberty too early. Testotoxicosis is a condition that causes early puberty in boys including growth in height, and development of muscles and sexual organs. Boys aged 2 years or above with clinical diagnosis of testotoxicosis and bone age of less than or equal to 10 years may be eligible. Research site located in Osnabruck, Germany.
